Spring til hovednavigation Spring til søgning Spring til hovedindhold

A Gain-of-Function p53-Mutant Oncogene Promotes Cell Fate Plasticity and Myeloid Leukemia through the Pluripotency Factor FOXH1

  • Evangelia Loizou
  • , Ana Banito
  • , Geulah Livshits
  • , Yu-Jui Ho
  • , Richard P Koche
  • , Francisco J Sánchez-Rivera
  • , Allison Mayle
  • , Chi-Chao Chen
  • , Savvas Kinalis
  • , Frederik O Bagger
  • , Edward R Kastenhuber
  • , Benjamin H Durham
  • , Scott W Lowe
85 Citationer (Scopus)

Abstract

Mutations in the TP53 tumor suppressor gene are common in many cancer types, including the acute myeloid leukemia (AML) subtype known as complex karyotype AML (CK-AML). Here, we identify a gain-of-function (GOF) Trp53 mutation that accelerates CK-AML initiation beyond p53 loss and, surprisingly, is required for disease maintenance. The Trp53R172H mutation (TP53R175H in humans) exhibits a neomorphic function by promoting aberrant self-renewal in leukemic cells, a phenotype that is present in hematopoietic stem and progenitor cells (HSPC) even prior to their transformation. We identify FOXH1 as a critical mediator of mutant p53 function that binds to and regulates stem cell-associated genes and transcriptional programs. Our results identify a context where mutant p53 acts as a bona fide oncogene that contributes to the pathogenesis of CK-AML and suggests a common biological theme for TP53 GOF in cancer. SIGNIFICANCE: Our study demonstrates how a GOF p53 mutant can hijack an embryonic transcription factor to promote aberrant self-renewal. In this context, mutant Trp53 functions as an oncogene to both initiate and sustain myeloid leukemia and suggests a potential convergent activity of mutant Trp53 across cancer types.This article is highlighted in the In This Issue feature, p. 813.

OriginalsprogEngelsk
TidsskriftCancer Discovery
Vol/bind9
Udgave nummer7
Sider (fra-til)962-979
Antal sider18
ISSN2159-8274
DOI
StatusUdgivet - jul. 2019

Fingeraftryk

Dyk ned i forskningsemnerne om 'A Gain-of-Function p53-Mutant Oncogene Promotes Cell Fate Plasticity and Myeloid Leukemia through the Pluripotency Factor FOXH1'. Sammen danner de et unikt fingeraftryk.

Citationsformater